Publications

1. Christner, J.; Takagishi, J.; Earley, M.; Dabrow, S.; and McCoy, R. Lessons Learned from Community Sites in a Pediatric Advocacy Rotation. Submitted to Supplement to Ambulatory Pediatrics, November 27, 2002.
2. Bilella, M., and Cohen Takagishi, J. Patient with Streptococcal Infection and Erythema Nodosum. Pediatrics in Review-Index of Suspicion. In press for August 2003.
3. Takagishi, J.; Bowers, L.; Gereige, R.; and Dabrow, S. Teaching the "Business of Medicine: via Multi-format Modules. Presented at Association of Pediatric Program Directors poster session (May 2, 2003).
4. Takagishi, J.; Christner, J.; Dabrow, S.; and McCoy, R. Lessons Learned from Community Sites in a Pediatric Advocacy Rotation. Presented at Association of Pediatric Program Directors poster session (May 2, 2003).
5. Christner, J.; Takagishi, J.; Earley, M.; Dabrow, S.; and McCoy, R. Lessons Learned from Community Sites in a Pediatric Advocacy Rotation. Ped Research-Part 2; 2003 April; 53 (4); 99A.
6. Cohen Takagishi, J. and Maldonado, L. Breast-feeding Rate at a Medicaid Clinic. The Florida Pediatrician. February, 2003.
7. Takagishi, J. C. and Maldonado, L. Breastfeeding Rate at a Medicaid Clinic. Ped Research-Part 2; 2002 May; 51 (4); 223A.
8. Schwarz, S. M.; Corredor, J.; Fisher-Medina, J.; Cohen, J.; and Rabinowitz, S. Diagnosis and Treatment of Feeding Disorders in Children with Developmental Disabilities. Pediatrics; 2001 Sept.; 108 (3); 671-676.
9. Corredor, J.; Ganesh, J.; Cohen, J.; and Schwarz, S.M. Diagnosis and Treatment of Feeding Disorders Improve Nutritional Status and Decrease Morbidity in Children with Developmental Disabilities. Abstract presented at annual meeting of the North American Society of Pediatric Gastroenterology and Nutrition, 1999.
10. Cronin-Golomb, A.; Corkin, S.; Rizzo, J.; Cohen, J.; Growdon, J.H.; and Banks, K. Visual Dysfunction in Alzheimer's Disease: Relation to Normal Aging. Ann. Neurol; 1991 Jan; 29 (1); 41-52.
11. Parkinson Study Group. Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease. New Engl. Journ. of Med. 1989 Nov 16; 321; 1364-1371.
12. Parkinson Study Group. DATATOP: A Multicenter Controlled Clinical Trial in Early Parkinson's Disease. Arch. Neurol. 1989 Oct; 46; 1052-1060.
13. Morris, J.C.; Heyman, A.; Mohs, R.C.; Hughes, J.P.; Van Belle, G; Fillenbaum, G.; Mellits, E.D.; Clark, C. and the CERAD Investigators. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part 1. Clinical and Neuropsychological Assessment of Alzheimer's Disease. Neurolog, 1989 Sept; 39 (9); 1159-65.
14. Cohen, J.; Cronin-Golomb, A.; Growdon, J.H.; and Corkin, S. Color Vision Deficits in Alzheimer's disease. Soc. Neurosci. Abstr.; 1988; Vol. 14; Part I; 219.
15. Cohen, J. and Gabrieli, J.D.E. Interactions Between Kinds of Memory in the Acquisition of a Perceptual Skill. Poster presentation at 14th Annual Greater Boston Undergraduate Research Paper Conference, 1987.

Research Projects

1. Weathers, L.; Takagishi, J.; Rodriguez, L. Community Pediatrician's Views on Umbilical Cord Care Policy Change. Data analysis in progress.
2. Christner, J.; Takagishi, J.; Dabrow, S. and McCoy, R. Lessons Learned from Residents in a Pediatric Advocacy Rotation. Data analysis in progress.
3. Degryse, A.; Takagishi, J. Septic Arthritis, Electrolyte Disturbance, and Glomerulonephritis Secondary to Group A B-hemolytic Streptococcal Infection. Case report in progress.
4. Comparison of the Safety, Tolerability, and Immunogenicity of P32 Process Upgrade Varicella Vaccine (PUVV) to P31 PUVV When Each is Administered Concomitantly With M-M-R II to Subjects 12 to 23 Months of Age. Merck & Co., Inc., B. Pollara, M.D., Ph.D., Principal Investigator, L. Nelson, A.R.N.P., M.S.N., C. Jahrsdorfer, R.N., B.S.N., L. Weathers, M.D., M. G. Silver, M.D., M. Cooper, M.D., S. Dabrow, M.D., C. Lilly, M.D., L. Maldonado-Lopez, M.D., L. Ringenberg, M.D., L. Rodriguez, M.D., E. Theophilopoulos, M.D., L. Scalfano, M.D., Jennifer Cohen Takagishi, M.D., 2000-Present.
5. Administration of Frozen Measles, Mumps, Rubella, and Varicella Vaccine (MMRV) to Healthy Children at 4 to 6 Years of Age. Merck & Co., Inc., B. Pollara, M.D., Ph.D., Principal Investigator, L. Nelson, A.R.N.P., M.S.N., C. Jahrsdorfer, R.N., B.S.N., L. Bowers, M.D., J. Cohen Takagishi, M.D., S. Dabrow, M.D., R. Gereige, M.D., C. Lilly, M.D., L. Maldonado, M.D., L. Ringenberg, M.D., L. Rodriguez, M.D., E. Theophilopoulos, M.D., L. Weathers, M.D., L. Dawson, R.N., T. Hesse, R.N., 2001-Present.
6. Safety and Efficacy of Pentavalent (G1, G2, G3, G4, and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants. Merck & Co., Inc., B. Pollara, M.D., Ph.D., Principal Investigator, L. Nelson, A.R.N.P., M.S.N., C. Jahrsdorfer, R.N., B.S.N., L. Bowers, M.D., J. Cohen Takagishi, M.D., S. Dabrow, M.D., R. Gereige, M.D., C. Lilly, M.D., L. Maldonado, M.D., L. Ringenberg, M.D., L. Rodriguez, M.D., E. Theophilopoulos, M.D., L. Weathers, M.D., 2001-Present.